logo
Plus   Neg
Share
Email

GSK: Phase 3 PRIMA Study Of ZEJULA To Treat Ovarian Cancer Meets Primary Goal

GlaxoSmithKline plc (GSK.L, GSK) announced Monday positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy.

The company said its Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA met its primary endpoint of a statistically significant improvement in progression free survival for women regardless of their biomarker status.

The safety and tolerability profile of niraparib was consistent with previous clinical trials. The company will present the full results from PRIMA at an upcoming scientific meeting.

Hal Barron, Chief Scientific Officer and President, R&D,GSK, said, "Almost 300,000 women around the world are diagnosed with ovarian cancer every year, yet only about 15% of patients are currently eligible to receive PARP inhibitors as their initial therapy. These exciting data demonstrate that ZEJULA has the potential to significantly benefit even more women with this devastating cancer."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the third quarter on Thursday, branded food company Hormel Foods Corp. (HRL) reaffirms its earnings guidance for the full-year 2019, while trimming annual net sales outlook as its navigates near-term uncertainty related to African swine fever. For fiscal 2019,... The U.S. Food and Drug Administration has issued a warning letter to Ningbo Huize Commodity Co., an over-the-counter drug manufacturer, for significant current good manufacturing practice violations, including data integrity issues. The warning letter issued to Ningbo Huize details a failure to have... Crate and Barrel have recalled 1,500 push walkers due to risk of choking and laceration. Crate and Barrel have recalled Activity Push Walkers as those walkers can be damaged over time exposing sharp points and small parts, posing choking and laceration hazards to small children. The wooden recalled...
Follow RTT